As ventilator-associated pneumonia increases, empiric therapy should be based on local
pathogen etiology and antibiotic resistant patterns. A new approach to consider is to start …

Background Nosocomial and ventilator-associated pneumonia (VAP) are causes of
significant morbidity and mortality in hospitalized patients. We analyzed a) the incidence and …

Objective To define the influence of prior antibiotic use on the etiology and mortality of
ventilator-associated pneumonia (VAP). Setting A university hospital medical-surgical ICU …

Ventilator-associated pneumonia (VAP), which is usually defined as an infection occurring
greater than 48 hours after hospital admission in a patient requiring mechanical ventilation …

The prevalence of multidrug-resistant (MDR) Pseudomonas aeruginosa has increased over
the past decade and a significant rise in these isolates in ventilator-associated pneumonia …

Hospital-associated pneumonia (HAP) is one of the most common infections acquired
among hospitalized patients. HAP is associated with excess mortality and increased medical …

Several guidelines base the empirical therapy of ventilator-associated pneumonia (VAP) on
the time of onset. However, there is emerging evidence that the isolated microorganisms …

Background The impact on ventilator-associated pneumonia (VAP) occurrence of a
multifaceted program, including progressive strategies for VAP prevention, implemented in …

The aim of this study was to determine the characteristics of carbapenem-resistant
Pseudomonas aeruginosa (P. aeruginosa) strains and 5-year changes in resistance in a …

Background: The initial empirical therapy of Ventilator Associated Pneumonia (VAP)
modified based on the knowledge of local microbiological data is associated with decreased …